Clinical Trial Update: An Investigational Drug Study Evaluating a Novel Approach to Treat Dyslipidemia (0524A-032) [Phase 2]

View source ↗

Summary

A Phase 2 investigational drug study for dyslipidemia has completed. The snippet does not provide efficacy results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dyslipidemia

Drugs mentioned

• Investigational drug 0524A-032

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Dyslipidemia | Phase 2 | Status: COMPLETED